Colorectal Cancer Clinical Trials in Baltimore

Showing 201-220 of 322 trials

The National CT Colonography Trial

NCT00084929

RATIONALE: New diagnostic procedures such as computed tomographic colonography may improve the ability to detect colorectal cancer and may provide a less invasive method of detection. PURPOSE: This clinical trial is studying how well computed tomographic colonography works in screening healthy participants for colorectal cancer.

Colorectal Cancer

American College of Radiology Imaging Network2,600 participantsStarted Feb 2005

Scottsdale, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +11 more locations

TERMINATEDPhase 3< 1 mile

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

NCT00023868

RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. Chemoembolization kills tumor cells by blocking the blood flow to the tumor and keeping chemotherapy drugs near the tumor. It is not yet known if chemoembolization is more effective than standard chemotherapy in treating metastatic cancer. PURPOSE: This phase I trial and randomized phase III trial is studying the effectiveness of chemoembolization in treating patients who have colorectal cancer metastatic to the liver.

Colorectal CancerMetastatic Cancer

American College of Radiology Imaging NetworkStarted Nov 2001

Tucson, Arizona, United States • Tampa, Florida, United States • Chicago, Illinois, United States +6 more locations

The National CT Colonography Trial

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Colorectal Cancer Trials in Other Cities

Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas

Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Plasma-based Colorectal Cancer Screening Research & Development

Longitudinal Performance of Epi proColon

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation

Other Conditions in Baltimore